To explore remedial strategy for gravidas with high HBV DNA load to prevent mother-to-infant transmission during late gestation

Jing WANG,Jin-feng LIU,Fu-lian ZHAO,Hong-bing LI,Hui-ping SHENG,Na LIU,Hai-sheng SU,Wen-xuan ZHAO,Ying-ren ZHAO,Tian-yan CHEN

DOI: https://doi.org/10.3969/j.issn.1673-5293.2017.12.022

2017-01-01

Abstract:Objective To compare the efficacy of telbivudine (LdT ) alone and LdT combined with hepatitis B immunoglobulin (HBIG) for gravidas with high HBV DNA load through large sample and prospective control study and to provide some data for preventing mother-to-infant transmission during late gestation .Methods Five hundred and seventy-four gravidas with chronic HBV infection visiting the First Affiliated Hospital of Xi'an Jiaotong University from January 2010 to December 2015 were enrolled in this study .Among them ,329 patients received LdT intervention ,180 patients received LdT + HBIG intervention ,and 65 patients received no intervention .Kinetics of HBV DNA load in pregnancy and safety after intervention were monitored .Results Compared to the control group ,HBV DNA load of gravidas both in LdT group and LdT + HBIG group declined obviously (F value was 202 .589 and 171 .347 ,respectively ,both P < 0 .05) .Compared to LdT group ,HBV DNA load in LdT + HBIG group dropped more significantly at the first 4 weeks after treatment (t = - 2 .427 , P < 0 .05) .Although there was no significant difference in proportion of patients whose HBV DNA load dropped below 106 IU /mL and 104 IU /mL at delivery between LdT group and LdT +HBIG group ,proportion of patients whose HBV DNA load dropped into safer range of below 103 IU /mL at delivery in LdT +HBIG group was significantly higher than that in LdT group (χ2 = 4 .476 , P < 0 .05) .Maternal and infant tolerance was good and adverse reactions were mild and no patients stopped intervention because of adverse reaction in LdT group and LdT + HBIG group . Differences in cesarean section rate ,premature birth rate and infant deformity rate were not significant in three groups (all P >0 .05) .Non and hypo response rate of infants in LdT group and LdT + HBIG group was not significantly different compared to that in the control group (χ2 value was 0 .422 and 0 .222 ,respectively ,both P > 0 .05) .Conclusion LdT combined with HBIG intervention during pregnancy can rapidly and safely depress HBV DNA load in high risk gravidas ,which can be measures for blocking mother-to-infant transmission of HBV .